Kardigan

Kardigan is a biotechnology company focused on revolutionizing cardiovascular drug development to address heart disease, the leading cause of death globally. With headquarters in South San Francisco and Princeton, NJ, the company employs approximately 60 people and is driven by a mission to make cardiovascular disease preventable and curable. Founded by a team that includes alumni from MyoKardia, Kardigan launched with $300 million in funding and a late-stage portfolio of personalized medicines. The company leverages patient-driven approaches to deliver innovative treatments aimed at transforming heart health outcomes.

Recent Posts by Kardigan

1-17 of 17